← Back to Search

Jaspr Health App for Suicidal Thoughts

N/A
Waitlist Available
Led By Linda A. Dimeff, PhD
Research Sponsored by Evidence-Based Practice Institute, Seattle, WA
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18+ years of age
Be older than 18 years old
Must not have
Severe depression (PHQ-9 score of 20 or greater)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (time 1), 4 weeks (time 2), 8 weeks (time 3), 12 weeks (time 4)
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new expanded Jaspr2.0 to efficiently and reliably aid delivery of recommended best-practices for the treatment of suicidal ideation in adults, including suicidal individuals who also misuse alcohol.

Who is the study for?
Adults over 18 with suicidal thoughts, who have seen their primary care provider in the past year, use a smartphone with data, and may misuse alcohol can join. Those with severe depression or alcohol dependence, acute suicidal tendencies, or significant drug abuse cannot participate.
What is being tested?
The trial is testing Jaspr2.0 app against an active control (Virtual Hope Box + wellness resources) for helping adults manage suicidal ideation and alcohol misuse. It's a randomized study assessing participants at multiple points over 12 weeks.
What are the potential side effects?
Since this trial involves digital interventions rather than medications, traditional side effects are not expected; however, users might experience emotional discomfort or distress from the content.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have severe depression based on my PHQ-9 score.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (time 1), 4 weeks (time 2), 8 weeks (time 3), 12 weeks (time 4)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (time 1), 4 weeks (time 2), 8 weeks (time 3), 12 weeks (time 4) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Alcohol Use Disorders Identification Test
Change in Patient Health Questionnaire-9
Change in Suicidal Behaviors Questionnaire-Revised
+1 more
Secondary study objectives
App Satisfaction Survey
Change in Suicide Attempt Self-Injury Interview
Other study objectives
Ask Suicide Screening Questions
Columbia-Suicide Severity Rating Scale
Demographics Questionnaire
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Jaspr2.0Experimental Treatment1 Intervention
Suicide prevention platform that includes evidence-based practices for suicide prevention and alcohol misuse for use in primary care. Jaspr2.0 includes psychoeducation, behavioral skills training, crisis stabilization planning, lethal means management, brief interventions for the treatment of alcohol misuse, and messages of hope, wisdom, and insights from people with lived experience (PLE). Participants in this condition will also have access to the Jaspr2.0 companion mobile app, Jaspr-at-Home.
Group II: Active-Control app + electronic wellness resources brochureActive Control1 Intervention
Well-regarded suicide prevention self-help app, plus an electronic wellness resources brochure containing links to health and wellness materials, psychoeducation about suicide, depression, self-help recovery-focused resources (e.g., Alcoholics Anonymous, other 12-Step programs, Moderation Management, etc.), and phone/text information for the National Suicide Prevention Lifeline.

Find a Location

Who is running the clinical trial?

Evidence-Based Practice Institute, Seattle, WALead Sponsor
8 Previous Clinical Trials
29,657 Total Patients Enrolled
6 Trials studying Suicide
29,343 Patients Enrolled for Suicide
Linda A. Dimeff, PhDPrincipal InvestigatorChief Scientific Officer
1 Previous Clinical Trials
88 Total Patients Enrolled

Media Library

Jaspr2.0 Clinical Trial Eligibility Overview. Trial Name: NCT05427734 — N/A
Suicide Research Study Groups: Jaspr2.0, Active-Control app + electronic wellness resources brochure
Suicide Clinical Trial 2023: Jaspr2.0 Highlights & Side Effects. Trial Name: NCT05427734 — N/A
Jaspr2.0 2023 Treatment Timeline for Medical Study. Trial Name: NCT05427734 — N/A
~80 spots leftby Aug 2025